Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xiamen Winbio Biotechnology Co., Ltd. (also known as Winbio Biotechnology) is a specialized biotechnology company based in the biopharmaceutical industrial park of Haicang District, Xiamen, China. Established in 2014, the company focuses on the research, development, global sourcing, and distribution of high-quality raw materials for in vitro diagnostic (IVD) applications. Its comprehensive product portfolio includes recombinant antigens, monoclonal and polyclonal antibodies, colloidal gold conjugates, and rapid test kit components. Winbio Biotechnology serves as a reliable partner for diagnostic reagent manufacturers worldwide, catering to diagnostic areas such as infectious diseases, oncology, hormone testing, and drug abuse screening. The company's products are widely utilized in academic research and commercial diagnostic assays, including lateral flow immunochromatographic tests.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on WINBIO.